Cvs Health Corp. (CVS) Stock Price Declined While Roffman Miller Associates Cut Stake; As Agrium (AGU) Stock Price Were Volatile, Shareholder Montrusco Bolton Investments Decreased by $31.42 Million Its Holding

May 27, 2018 - By Peter Erickson

Agrium Inc. (NYSE:AGU) Logo

Roffman Miller Associates Inc decreased its stake in Cvs Health Corp. (CVS) by 6.13% based on its latest 2017Q4 regulatory filing with the SEC. Roffman Miller Associates Inc sold 9,311 shares as the company’s stock declined 17.45% with the market. The institutional investor held 142,641 shares of the medical and nursing services company at the end of 2017Q4, valued at $10.34 million, down from 151,952 at the end of the previous reported quarter. Roffman Miller Associates Inc who had been investing in Cvs Health Corp. for a number of months, seems to be less bullish one the $67.13B market cap company. The stock increased 1.40% or $0.91 during the last trading session, reaching $66.03. About 5.56 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 27, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Montrusco Bolton Investments Inc decreased its stake in Agrium Inc (AGU) by 38.33% based on its latest 2017Q4 regulatory filing with the SEC. Montrusco Bolton Investments Inc sold 273,214 shares as the company’s stock 0.00% . The institutional investor held 439,513 shares of the agricultural chemicals company at the end of 2017Q4, valued at $50.72M, down from 712,727 at the end of the previous reported quarter. Montrusco Bolton Investments Inc who had been investing in Agrium Inc for a number of months, seems to be less bullish one the $ market cap company. The stock increased 0.36% or $0.41 during the last trading session, reaching $115. About 833,843 shares traded or Infinity% up from the average. Agrium Inc. (NYSE:AGU) has 0.00% since May 27, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 25 analysts covering Agrium Inc. (NYSE:AGU), 14 have Buy rating, 2 Sell and 9 Hold. Therefore 56% are positive. Agrium Inc. had 78 analyst reports since August 6, 2015 according to SRatingsIntel. Citigroup maintained Agrium Inc. (NYSE:AGU) rating on Monday, August 14. Citigroup has “Neutral” rating and $100 target. The rating was maintained by RBC Capital Markets with “Buy” on Monday, October 16. The rating was maintained by BMO Capital Markets on Thursday, July 6 with “Hold”. The company was maintained on Wednesday, November 22 by Cowen & Co. TD Securities downgraded the stock to “Hold” rating in Wednesday, October 21 report. On Monday, October 5 the stock rating was maintained by Barclays Capital with “Overweight”. The firm has “Hold” rating given on Monday, April 24 by Credit Suisse. As per Friday, November 4, the company rating was downgraded by Credit Suisse. The firm has “Market Perform” rating given on Tuesday, September 13 by BMO Capital Markets. The stock has “Buy” rating by Canaccord Genuity on Friday, August 7.

Montrusco Bolton Investments Inc, which manages about $6.00 billion and $1.83B US Long portfolio, upped its stake in Stantec Inc (NYSE:STN) by 23,172 shares to 503,623 shares, valued at $14.13 million in 2017Q4, according to the filing. It also increased its holding in Qualcomm Inc (NASDAQ:QCOM) by 35,690 shares in the quarter, for a total of 41,015 shares, and has risen its stake in Transcanada Corp (NYSE:TRP).

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. On Monday, May 9 the stock rating was maintained by Citigroup with “Neutral”. As per Monday, December 4, the company rating was maintained by Needham. The company was reinitiated on Wednesday, August 19 by Evercore. The stock has “Overweight” rating by Morgan Stanley on Friday, January 5. The rating was maintained by Leerink Swann with “Outperform” on Tuesday, November 7. The company was maintained on Wednesday, January 17 by Robert W. Baird. The company was maintained on Friday, October 27 by Robert W. Baird. The stock of CVS Health Corporation (NYSE:CVS) earned “Strong Buy” rating by S&P Research on Monday, November 2. As per Monday, August 14, the company rating was downgraded by Wolfe Research. Mizuho maintained the shares of CVS in report on Wednesday, January 24 with “Buy” rating.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on August, 14. They expect $1.61 EPS, up 21.05% or $0.28 from last year’s $1.33 per share. CVS’s profit will be $1.64B for 10.25 P/E if the $1.61 EPS becomes a reality. After $1.48 actual EPS reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 8.78% EPS growth.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “CVS: Going Long, And Understanding The Aetna Deal” on April 30, 2018, also Seekingalpha.com with their article: “We Are Playing The CVS Hand” published on May 11, 2018, Seekingalpha.com published: “Trade Mistake 3: CVS Boredom Trade” on May 09, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Fool.com and their article: “Why CVS Health Stock Gained 12% in April” published on May 08, 2018 as well as Investorplace.com‘s news article titled: “Aetna Inc (AET) Slims and Trims Before Marriage to CVS” with publication date: May 01, 2018.

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It is negative, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Arizona State Retirement Systems holds 0.22% in CVS Health Corporation (NYSE:CVS) or 309,362 shares. Kentucky Retirement Insur Trust Fund has 26,902 shares for 0.33% of their portfolio. Glob Endowment Ltd Partnership owns 49,500 shares. Ls Investment Advsrs Limited Liability Corporation invested 0.8% in CVS Health Corporation (NYSE:CVS). Thompson Mgmt Incorporated has 91,281 shares. Private Advisor Ltd Co holds 24,635 shares. Stratos Wealth Prns holds 0.24% in CVS Health Corporation (NYSE:CVS) or 74,971 shares. Todd Asset Mngmt Limited Liability Co owns 198,311 shares for 0.39% of their portfolio. Nelson Van Denburg & Campbell Wealth Mngmt Group Ltd Llc owns 235 shares or 0% of their US portfolio. Quinn Opportunity Prns Ltd Co reported 12,850 shares stake. Lipe Dalton holds 46,966 shares. Arvest Commercial Bank Trust Division invested in 0.96% or 189,380 shares. Pinnacle Ptnrs has invested 0.31% of its portfolio in CVS Health Corporation (NYSE:CVS). Canandaigua National Bank & Trust & Tru has invested 0.61% in CVS Health Corporation (NYSE:CVS). Reliance Communication Of Delaware holds 0.47% or 42,568 shares.

Roffman Miller Associates Inc, which manages about $833.24 million and $810.76M US Long portfolio, upped its stake in Exxon Mobil Corporation (NYSE:XOM) by 6,209 shares to 218,272 shares, valued at $18.26 million in 2017Q4, according to the filing. It also increased its holding in Alphabet Inc. by 596 shares in the quarter, for a total of 17,143 shares, and has risen its stake in Starbucks Corp (NASDAQ:SBUX).

Since February 16, 2018, it had 2 insider buys, and 1 insider sale for $713,454 activity. DORMAN DAVID W bought $1.51M worth of stock or 24,300 shares. Shares for $619,900 were bought by BROWN C DAVID II on Friday, May 4.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>